MEDCHEM 562P 2014 - VITAMINS and Minerals

Part 1: Water Soluble Vitamins

Bill Atkins Ph.D. H172Q, 685 0379; winky@u.washington.edu INTRODUCTION I. Who takes vitamin/mineral supplements and why? [Bailey et al. JAMA Intern

Med 173:355 (2013].

• It is estimated that ~50% of the adult population in the US takes some type of dietary supplement, typically to ‘improve/maintain overall health’.

• >75% of products are used without care-provider recommendation.

2

II. Multivitamins

It is estimated that ~30% of the adult US population take multivitamins daily. A recent clinical trial of male physicians taking multivitamins concluded there was a

very modest, but (statistically) significant, reduction in total cancers with daily multivitamin use (NEJM, 308:1871 (2012).

Do we need to supplement diets with vitamins/multivitamins? Maybe…. in certain circumstances.

III. When are vitamin supplements worthwhile?

Inadequate intake -- alcoholics, poor, elderly, dieters, poor diet

Increased needs -- pregnancy, lactation, infants, smokers, injury, trauma, recovery from surgery, infection

Poor absorption -- elderly, GI disorders, specific GI surgeries, e.g. gallbladder

removal, gastric bypass, cystic fibrosis, severe diarrhea, drug-induced vitamin deficiencies – e.g. long term antibiotic use, cholestyramine, mineral oil

IV. Definitions

• Vitamins are organic compounds and minerals are chemical elements that are required as nutrients in small amounts by an organism.

• Vitamers are different forms of a particular vitamin, e.g. vitamins K1 and K2, vitamins D2 and D3, retinol and retinal, etc.

3

V. Reference Tables for Intake of Vitamins and Elements Intakes DRI Reports are produced by the Food & Nutrition Board of the Institute of

Medicine, National Academies of Science. http://fnic.nal.usda.gov/dietary-guidance/dietary-reference-intakes/dri-tables

Estimated average requirements (EAR): the average daily nutrient intake level estimated to meet the requirements of half of the healthy individuals in a group.

Recommended Dietary Allowance (RDA): the average daily dietary intake level; sufficient to meet the nutrient requirements of nearly all (97-98%) healthy individuals in a group. Calculated from the EAR.

Tolerable Upper Limit (UL): maximum adult daily intake unlikely to cause harm.

RDA= 1.2(EAR)

Daily Values (DVs) are set by the FDA.

http://ods.od.nih.gov/HealthInformation/dailyvalues.aspx • Two groups: Daily Reference Values (DRVs) for energy-producing nutrients,

e/g. fats, carbohydrates, protein etc. and Reference Daily Intakes (RDIs) for vitamins and minerals.

• A DV is often, but not always, similar to one's RDA for that nutrient. • DV is primarily used for labeling purposes. % DV on label is based on 2,000

calorie/day diet for adults and children over 4 yrs.

4

VI. Standardization

• Units of biological activity (IU) superceded, where known, by potencies based on weight (µg, mg) of the most active vitamer.

• IoM guidelines use weight. • FDA labels use both.

  VII. History and Discovery 1500 BC Ancient Egyptians used liver - rich in vitamin A - applied to the eye to treat night

blindness.

1536 Jacques Cartier, exploring the St. Lawrence River, uses local native knowledge to save his men from scurvy by boiling the needles from cedar trees to make a vitamin C-rich tea.

1795 British navy adds lemons to sailors' rations, 40 years after a Scottish naval surgeon, James Lind, had urged that citrus fruits be used to prevent scurvy.

1884 Japanese navy eradicates beriberi - vitamin B1 deficiency- by feeding sailors meat and fruit in addition to polished white rice, which lacked the thiamine-rich husks.

1897 Beriberi (a polyneuritis) was induced in birds fed only polished rice and reversed by feeding the rice polishings.

1911 Casimir Funk isolates amine-containing concentrate containing thiamine from rice polishings, which was curative for polyneuritis in pigeons, and names it 'vitamine' for vital amine.

5

1912 Xavier Mertz –Antarctic explorer – dies of vitamin A poisoning from ingesting sled dog liver after supplies are lost in a crevasse.

Year discovered Vitamin Source

1912 Vitamin B1 Rice bran

1912 Vitamin C Lemons

1913 Vitamin A Milk/egg yolk

1918 Vitamin D Cod liver oil

1920 Vitamin B2 Eggs

1922 Vitamin E Wheat germ, Seed oils

1926 Vitamin B12 Liver

1929 Vitamin K Alfalfa

1931 Vitamin B5 Liver

1931 Vitamin B7 Liver

1934 Vitamin B6 Rice bran

1936 Vitamin B3 Liver

1941 Vitamin B9 Liver

6

VII. WATER SOLUBLE VITAMINS

A. Generalities 1. Metabolism and storage -- only B12 and folate are appreciably stored. In

general, water soluble vitamins are excreted readily and are not stored. As a result, depletion is more of a problem than toxicity.

2. Toxicity -- only niacin and pyridoxine are at all toxic (in high conc.). In general, the water soluble vitamins have few toxicities. The water soluble vitamins are coenzymes for various common biochemical reactions and their status can be readily determined by measuring the appropriate enzyme activities in blood. Typically, the enzyme activity is measured in the absence and the presence of exogenously added coenzyme, to determine whether the patient needs more of the vitamin.

B. Thiamin -- (Vitamin B1) 1. Structure

TMPN SCH2

CH3 N

N

CH3 CH2 CH2OH

Hthiamin

ATP ATPTPP

Chemically, the structure includes a pyrimidine ring and a thiazole ring. The thiazole ring has received enormous attention from mechanistic biochemists - they have pondered the reason for the choice by nature of a sulfur atom in the ring. Imidazole rings and oxazole rings would also, in principle, be capable of catalyzing the relevant chemical reactions.

Space-filling model of Thiamin

7

2. Function – used to harvest carbohydrates for energy a) Oxidative decarboxylation of α-keto acids

+

CH3 C CO2HO

TPP

lipoic acidNAD

CoASHpyruvate dehydrogenase complex

CH3 C SCoAO

CO2e.g. + + NADH

e.g. α -ketoglutaric acid TPP succinyl CoA CO2

NADCoASH

++

lipoic acidα-ketoglutarate dehydrogenase complex

8

The decarboxylation is accomplished by a mitochondrial enzyme complex as shown below. L = lipoic acid, E = enzyme, TPP = thiamin pyrophosphate. Pyruvate dehydrogenase complex in detail

b) Transfer of α-ketols (pentose phosphate pathway) -- 10% of carbohydrate metabolized this way. This pathway provides pentoses for RNA and DNA synthesis and NADPH for the biosynthesis of fatty acids and other endogenous reactions.

c) Non-coenzyme function – TTP involved in the control of chloride channels in brain and elsewhere in nerve impulse conduction.

E LSH

SH

CoASH

CH3 CSCoAO

NAD+

TCAcycle

E TPP

E TPP

C OH

CH3

(α-hydroxyethyl TPP)

E LS

S

E L SH

S C CH3O

CH3 C COOHO

CO2

NADH

CHOHCHO

CH2OPO3H2

+O=

HOCHCCH2OH

HCOH

HCOH

HCOHCH2OPO3H2

CHOHCHOH

CHOH

CHO

CH2OPO3H2

+O=

HO CHCCH2OH

HC OHCH2OPO3H2

TPPtransketolase

e.g.

xyulose-5-phosphate ribose-5-phosphate

sedoheptulose-7-phosphate

glyceraldehyde phosphate

9

3. Mechanism – formation of adduct with C2 of thiazole ring. ‘Classic’ experiments support this mechanism, including facile exchange of solvent D2O at the C-2 position.

4. Deficiency – thiamin needs are proportional to caloric intake and is essential for carbohydrate metabolism. Usually consider requirement as 0.5 mg/1000 calories plus 0.3 mg during pregnancy and lactation. Studies show laboratory evidence of thiamin deficiency (erythrocyte transketolase assay) in 20-30% of elderly patients and 40-50% of chronic alcoholics. <2% of healthy controls showed evidence of deficiency. a) Early signs of deficiency – anorexia, nausea, vomiting, fatigue,

weight loss, nystagmus, tachycardia.

b) Late signs of deficiency – Beriberi cardiac - increased heart size, edema cerebral - depression, irritability, memory loss, lethargy GI tract - vomiting, nausea, weight loss neurological - weakness, polyneuritis, convulsions. Signs and symptoms vary with age of patient, rapidity of onset, and severity of deficiency.

+H

+H

N S

CCH3

OH

NC

S

CHCH3

OH

NC

S

H

H+ + CH3 CHO

α-hydroxy-ethyl-TPP

H+

N S

CCH3 OH

C OO

3 2 H++NC

S

H

NC

S

CH3 C COOH

O

NC

Spyruvate

H+

CH3 C COOH

O

10

c) Thiamine and the alcoholic (i) intake low and alcohol blocks conversion of thiamin

→ TPP (ii) ↓ absorption - ↓ active transport (iii) ↓ storage (iv) increased fluid intake and urine flow causes thiamin

washout (v) involved in fetal alcohol syndrome.

d) Wernicke-Korsakoff syndrome – seen in some alcoholics;

neurological disorder resulting in impaired mental functioning → institutionalization for a significant number of patients. Symptoms: confusion, memory loss, confabulation, psychotic behavior; maybe irriversible in part.

e) Factors → B1 deficiency (i) ↑ carbohydrate intake -- TPN, alcoholics (ii) ↓ absorption -- ulcerative colitis, etc., alcoholism (iii) ↓ intake -- poor diet, geriatrics, breast fed infant from B1

deficient mother, etc. (iv) alcoholism.

f) Cellular uptake – Intestinal cells contain a thiamin specific

receptor/transporter (hTHTR) which appears to specifically pump thiamin and not TPP. After cellular uptake, thiamin is converted to TPP. Polymorphisms in the gene encoding hTHTR are known and may contribute to thiamin-responsive megaloblastic anemia. Once in the circulation specific transport proteins may ‘store’ TPP and control its circulation (hypothesized), but most is bound to Albumin. Most ends up in skeletal muscle, brain, heart, liver.

5. Source – present in most tissues (as TPP) and plants (as thiamin); rich sources include: lean meat, especially pork, cereal grains, eggs, yeast, nuts. Thiaminase – in some fish (raw) and shellfish (raw) and ferns. This enzyme can hydrolyze thiamin.

NC

SCH2R

In the milling or processing or processing of rice and flour, the thiamin is lost. ‘Whole’ wheat or rice contains ~10 times as much Thiamin as white wheat or rice. Today in the USA, most white flour, rice and pastas are "enriched" to bring thiamin levels to near original levels. "Enriched" products also have added riboflavin, niacin, iron, and folic acid.

11

6. Stability – labile at pH > 4 and when heated (especially at alkaline pH values) prolonged cooking ¯ levels especially at pH > 4.

7. Diagnosis of deficiency state a) ↑ pyruvate and lactate in plasma b) transkelotase activity in RBC – most important technique.

8. Uses

a) deficiency states -- for alcoholics b) thiamin responsive inborn errors of metabolism -- see below c) mosquito repellant -- efficacy? -- for dogs, for humans 50 mg QID

2d before and during exposure is recommended. d) acute alcoholism: give 100 mg IM or IV stat. This is a common

practice. e) Alzheimer’s disease—little evidence for benefit (huge doses used).

9. Thiamin responsive inborn errors of metabolism:

Disease Defect Wernicke – Korsakoff Transketolase Maple Syrup urine disease Failure to decarboxylate branched chain amino acids Thiamin responsive megaloblastic anemia Hyperalanemia ? Hyperpyruvate acidurea Pyruvate dehydrogenase

10. Requirement – 0.5 mg/1000 cal. DV = 1.5 mg. Minimum intake should be at least 1 mg.

11. Toxicity – nontoxic on oral administration; No UL value. Anaphylactic reactions have been observed in patients receiving repetitive parenteral doses.

12. Patient Counseling/ Patient Use Issues a) Needed to drive carbohydrates to energy b) Rarely needed as a single supplement. Use a multivitamin to get

needed thiamin. c) Special benefit in alcoholics at higher doses d) Benefit in high doses in rare thiamin-responsive inborn errors of

metabolism e) Uncertain benefit as a mosquito repellant (if true, 1-2 week onset) f) Nontoxic.

12

C. Riboflavin (Vitamin B2) Like Vitamin B1, Riboflavin is highly water soluble, and it is difficult to achieve toxic levels in the body – excess vitamin is efficiently eliminated renally. It used as an additive in many enriched foods and can be produced in huge, industrial scale, quantities by expression of the biodynthetic enzymes in fungi or bacteria. These genetically engineered organisms may appear bright yellowish-orange, which is the color of Riboflavin. 1. Structure

riboflavin coenzymesFAD = flavin adenine dianucleotideFMN = riboflavin monophosphate

N

NNH

N

O

OCH3

CH3

CH2 CH CH CH CH2OHOH OH OH

gut mucosa liverriboflavin FMN FADATP ADP ATP ADP

13

2. Function – redox, tissue respiration, H transfer as flavin containing enzyme. oxidized – yellow reduced - colorless Examples of enzymes having flavin groups: succinate dehydrogenase (-succinate → fumerate in TCA cycle) fatty acid acyl CoA dehydrogenase (β-oxidation of lipids) glutathione reductase – important in antioxidant activities The following are important flavoproteins (containing FMN): Cytochrome C reductase (electron transport); NADP+ -- cytochrome C reductase; cytochrome P-450 reductase (drug metabolism), flavin monooxygenase (drug metabolism).

3. Deficiency state a) Not usually seen in isolation but occurs in combination with other

B vitamin deficiencies. b) Fatigue, cheilosis, glossitis, vascularization of cornea, dermatitis c) Vegans and teenagers may be low in B2 if dairy intake is low d) Low B2 intake may be a risk factor for cataract development e) Alcoholics are at risk due to low intake and low absorption.

4. Source – milk, meats, leafy vegetables, eggs, yeast, “enriched” products.

5. Stability

a) Usually > 30% destroyed by cooking b) Labile to light

red, colorlessox-yellow

R

NH

NH

HN

RO

O

RN

NNH

N O

O-2H⋅

⋅+2H

NADPH

NADP

FAD

FADH2

2GSH

GSSG

H2O2 or ROOH

2H2O or ROH + H2O

glutatione peroxidaseglutathionereductase

14

c) More stable in acid than alkali in absence of light.

6. Use a) Deficiency states. Is a component of most multivitamin mixtures. b) New – may help in migraine headache prevention. c) New – high intake associated with lower risk for cataracts and a

3mg supplement reduced risk.

7. Requirements a) DV = 1.7 mg b) “Average” U.S. diet contains 2 mg for males and 1.5 mg for

females c) Diagnosis – erythrocyte glutathione rreductase activity d) No UL value

8. Patient Counseling/ Patient Use Issues

a) Routine single dose supplementation not needed. Use a

multivitamin to get needed riboflavin. b) Possible use in preventing migraine headaches. Use 400 mg/d. c) Will turn urine bright yellow in doses higher than the DV. d) Nontoxic.

D. Vitamin B6 1. Structure

Pyridoxine is a commonly used term for this vitamin, but all 3 are equally active so vitamin B6 is a better term to use. Three phosphorylated forms are present also: P PO4 PLP

FMNPNP

FMN

pyridoxamine (PN)

N

CH2OHHO

CH3

CH2NH2

N

CH2OHCH2OHHO

CH3

pyridoxine (P)

N

CH2OHHO

CH3

CHO

pyridoxal (PL)

15

Coenzyme = pyridoxal-5-phosphate “PLP”

2. Function – participates in over 140 enzymatic reactions by forming a Schiff base with the terminal amino group of lysine in the enzyme. It is estimated that this corresponds to ~4% of all enzymatic reactions known. a) Transamination

e.g. glutamate-aspartate transaminase

N

CH2OP

CH3

HOCH

O

R NH2

holoenzymeNCH3

HO CH2OPCHNR

PLP

PLP dependent enzyme

+

R C COOHO

α-keto acid #1

N

HO CH2OP

CH3

CHNenzyme

N

HO CH2OP

CH3

CHNCHR COOH

N

HO CH2OP

CH3

CHNCR COOHH

N

HO CH2OP

CH3

CHNH2

R CH COOHNH2

amino acid #1

+

+

H2O

+ R´ C COOHNH2

amino acid #2

+ R´ C COOHO

α-keto acid #2N

CH2

NH2

HO

CH3

CH2OP

N

HO

CH3

CH2OPCHO

PLPPNP

PLP

oxaloacetic acid alanineCH3 CH COOH

NH2

transaminasepyruvic acid

HOOC CH2 C COOHO

+

aspartic acid HOOC CH2 CH COOH

NH2+ CH3 C COOH

O

16

b) Decarboxylation e.g. e.g. e.g. e.g.

Note: B6 contraindicated in levo-DOPA therapy because B6 enhances peripheral decarboxylation of levo-DOPA to dopamine which will not cross Blood Brain Barrier; Larobec® (Roche) contains no pyridoxine and can be used if multivitamin supplementation is desired for patient on l-DOPA. The anti-Parkinsons’s drug Sinemet® contains levo-DOPA and carbidopa (A DOPA

N

HO CH2OP

CH3

CHO

N

HO CH2OP

CH3

CHNCHR COOH

N

HO CH2OP

CH3

CHO

CH2RNH2+

decarboxylase

H2O

amino acid

R CH COOHNH2 + + CO2

HOOC CH2 CH2 C COOHH

NH2PLP

CO2

HOOC CH2 CH2 C HH

NH2

glutamic acid γ-amino butyric acid (GABA)

N

HOC COOHH

NH2

5-hydroxytryptophan

N

HOCH2

NH2

5-hydroxytryptamine (serotonin)

CO2

PLP

PLP

CO2NN

CH2HCH

NH2

histamine

NNCH2

HC COOHNH2

histidine

PLP

CO2 CH2 CH2

OH

NH2

HOHO

CH2HC COOHNH2

OH

DOPA DOPAMINE

17

decarboxylase inhibitor) -- therefore, no interaction.

c) B6 and sulfur amino acid metabolism. (Note: elevated homocysteine is an independent risk factor for cardiovascular disease and birth defects.)

d) B6 involvement in methionine formation (and S-adenosyl methionine) makes it indirectly involved in methylation. Hence B6 is indirectly involved in lipid metabolism and nucleic acid formation and immune function.

C COOHCH2

H

NH2

CH2SCH3

OCH2

S CH2NH2

HCH2 COOCH

adenine

OHOH

-

OCH2

CH3 S CH2 CH2 COOCH

adenine

OHOH

H

NH2

-

C COOHCH2

H

NH2

H3C

C COOHCH2

H

NH2

HS

α-ketobutyrate

cysteine

cystathionine

PLP serine

methionine

S-adenosylmethionine

methyl acceptor

S-adenosylhomocysteine

THFA

N5-methylTHFA

methyl B12

hydroxy B12

ATP

C COOHCH2

H

NH2

CH2HS

homocysteine

C COOHCH2

H

NH2

CH2S

CH2 C COOHH

NH2

+

PLPcystathionineγ-lyase

18

e) B6 involved in tryptophan metabolism to serotonin and niacin.

f) Other reactions requiring B6: (i) Glycogen phosphorylase (release of glucose in muscle) (ii) Heme biosynthesis

NiacinN

COOH

COOH

NH2NH

tryptophanoxygenase

serotonintryptophan

COOH

NH2NH

HO

N-formylkynurenine

NH2NCHO

COOH

O

3-hydroxykynurenine

NH2

COOH

OHNH2

O

kynureninasePLP

COOH

NH2OH

3-hydroxy anthranilic acid

NNH2

HO

Htryp

decarboxylase

PLP

19

(iii) Nucleic acid biosynthesis (via SAM)

SUMMARY of Pyridoxal/pyridoxamine reactions

CH2

N

C

N

HC

HC

N

N

B:

external imine internal imine

HO-

H2C

C

N

HN

OH

external carbinolamine

HC

HC

N

HN

HO-

OH

internal carbinolamine

H2C

N

NH2

OHC

N

O

NH2

hydrolysis of Imine leads to incorporation of ‘oxygen atom’ H2O attacks carbon atom of the imine, that carbon gets an oxygen PLP enzymes control which carbon atom gets the oxygen atom by switching between the external imine and the internal imine.

20

3. Deficiency

a) Not seen usually and, if seen, is associated with other vitamin

deficiencies or is iatrogenic; symptoms include rash, peripheral neuritis, anemia and possible seizures. Deficiency diagnosed by low plasma PLP and low transaminase activities (±PLP).

b) Iatrogenic B6 deficiencies (i) Isoniazid – antituberculosis drug – forms Schiff base with

B6. Can get neuritis and convulsions. 25-300 mg/d B6 given to prevent B6 deficiency.

(ii) 4-Deoxypyridoxine – (experimental only)

N

HOCH3

CH2OH

CH3 Symptoms – Skin lesions on face, glossitis, stomatitis, convulsive seizures (↓ GABA?), anemia (↓ heme synthesis?).

(iii) Oral contraceptives.- older high dose Ocs can affect B6 but not a problem now.

4. Source – milk, meats, legumes, tuna, whole grains, beans.

5. Stability – pyridoxine is stable; some loss on cooking, especially with meats, due to Schiff base formation and decrease of the pyridoxal in the foods.

N

CO

NH NH2

N

HCO

CH2OHHO

CH3

+

N

CO

NH N CHO CH2OH

H

CH3

NIsoniazid

21

6. Diagnosis of Deficiency – measure erythrocyte transaminases.

7. Use a) Routine use in multivitamin products b) In INH therapy c) Certain inborn errors of metabolism

Name Symptoms Dose of B6 Problem

B6--dependent infantile convulsions

Clonic and tonic seizures

10-25 mg/day

Defective glutamic acid decarboxylase; possible GABA depletion

B6--responsive anemia

Microcytic, hypochromic anemia

100 mg/day

Defective hemoglobin synthesis

Xanthurenic acidurea Mental retardation 25-100 mg/day Defective tryptophan metabolism due to faulty kyureninase, xanthurenic acid spills into urine

Homocystinurea Mental retardation Early heart disease

25-500 mg/day Defective cystathionine synthetase homocysteine appears in urine

Cystathionurea Mental retardation 25-500 mg/day Defective cystathionase d) PMS (50-500 mg/d) -- evidence is uneven. PLP is known to bind

to steroid receptors.

e) Carpal tunnel syndrome -- evidence is uneven. It seems to work for some. A trial of B6 100-200 mg/d for 6 mos. may be worthwhile.

f) Use in lowering homocysteine levels (see sulfur amino acid scheme above). High homocysteine may be an independent risk factor for cardiovascular disease but this is now controversial. Combine with folic acid and B12 for optimum lowering action.

g) Nausea and vomiting in pregnancy-Helpful in high doses. PremesisRx contains 75mg sustained release B6 (plus 12ug B12, 1mg folic acid and 200mg calcium) or 25mg of generic B6 TID is less expensive.

8. Requirement – DV = 2 mg; UL = 100 mg.

9. Toxicity a) > 200 mg/day can decrease prolactin levels b) > 1-2 g/day can cause serious neuropathy by an unknown

mechanism. Recommendation: avoid long term use in doses above

22

200 mg.

10. Patient Counseling/ Patient Use Considerations a) Routine single dose supplementation usually not needed. Use a

multivitamin to get needed B6. b) Sometimes used, with limited evidence, for carpal tunnel

syndrome, PMS, and depression on OCs. c) Rare use in high doses for inborn errors. d) Sometimes used to prevent neuropathy with isoniazid. e) For nausea and vomiting of pregnancy, 25 mg TID or use

PremensisRx which is FDA approved for this. f) Used with B12 and folic acid in high homocysteine. g) Keep doses < 200 mg/d to avoid neuritis.